Pub Date : 2021-01-01DOI: 10.35248/2155-9570.21.12.866
Takashi Saito, M. Sakamoto, Izumi Yoshida, Ryuya Hashimoto, Takahiro Sodeno, Kenichiro Aso, H. Masahara, T. Maeno
Aim: To investigate the difference in postoperative Anterior Chamber Depth (ACD) following phacovitrectomy depending on the type of the vitreoretinal diseases, measured using optical biometry. Methods: We investigated 14 eyes of 14 patients (11 males, 3 females; mean age 59.4 ± 8.4 years) with Rhegmatogenous Retinal Detachment (RRD) without macular involvement who underwent phacovitrectomy (RRD group), 14 eyes of 14 patients (10 males, 4 females; mean age 68.4 ± 4.7 years) with a macular hole (MH) who underwent phacovitrectomy (MH group), 24 eyes of 24 patients (14 males, 10 females; mean age 66.5 ± 7.6 years) with Epi Retinal Membrane (ERM) who underwent phacovitrectomy (ERM group), and 42 eyes of 29 patients (15 males, 14 females; mean age 71.4 ± 11.8 years) without macular disease who underwent cataract surgery (cataract group). ACD was measured prior to surgery and one month after surgery using optical biometry and was compared between groups. Results: The mean difference in ACD (postoperative ACD minus preoperative ACD) was 0.68 ± 0.38 mm in the RRD group, 1.12 ± 0.32 mm in the MH group, 1.04 ± 0.56 mm in the ERM group, and 1.00 ± 0.47 mm in the cataract group. Postoperative ACD in the RRD group was shallower compared to the other groups. Conclusion: Postoperative ACD in patients with RRD is shallower compared to other groups, including patients with MH, making it one of the suspected causes of myopic shift in patients with RRD.
目的:利用光学生物测量技术，探讨玻璃体切除术后不同类型玻璃体视网膜病变的术后前房深度(ACD)的差异。方法:对14例患者的14只眼(男11例，女3例;平均年龄59.4±8.4岁，无黄斑受累的孔源性视网膜脱离(RRD)行晶状体切除术(RRD组)，14例14眼(男10例，女4例;平均年龄(68.4±4.7)岁，伴有黄斑裂孔(MH)行晶状体切除术(MH组)，24例24眼(男14例，女10例;平均年龄66.5±7.6岁)，29例42眼(男15例，女14例;平均年龄(71.4±11.8岁)，无黄斑病变，行白内障手术者(白内障组)。术前和术后1个月采用光学生物测量法测量ACD，并进行组间比较。结果:RRD组ACD(术后ACD减去术前ACD)的平均差值为0.68±0.38 mm, MH组为1.12±0.32 mm, ERM组为1.04±0.56 mm，白内障组为1.00±0.47 mm。RRD组术后ACD较其他组浅。结论:与包括MH患者在内的其他组相比，RRD患者术后ACD较浅，可能是RRD患者近视移位的原因之一。
{"title":"Changes in the Postoperative Anterior Chamber Depth in Eyes Following Phacovitrectomy in Several Vitreoretinal Diseases","authors":"Takashi Saito, M. Sakamoto, Izumi Yoshida, Ryuya Hashimoto, Takahiro Sodeno, Kenichiro Aso, H. Masahara, T. Maeno","doi":"10.35248/2155-9570.21.12.866","DOIUrl":"https://doi.org/10.35248/2155-9570.21.12.866","url":null,"abstract":"Aim: To investigate the difference in postoperative Anterior Chamber Depth (ACD) following phacovitrectomy depending on the type of the vitreoretinal diseases, measured using optical biometry. Methods: We investigated 14 eyes of 14 patients (11 males, 3 females; mean age 59.4 ± 8.4 years) with Rhegmatogenous Retinal Detachment (RRD) without macular involvement who underwent phacovitrectomy (RRD group), 14 eyes of 14 patients (10 males, 4 females; mean age 68.4 ± 4.7 years) with a macular hole (MH) who underwent phacovitrectomy (MH group), 24 eyes of 24 patients (14 males, 10 females; mean age 66.5 ± 7.6 years) with Epi Retinal Membrane (ERM) who underwent phacovitrectomy (ERM group), and 42 eyes of 29 patients (15 males, 14 females; mean age 71.4 ± 11.8 years) without macular disease who underwent cataract surgery (cataract group). ACD was measured prior to surgery and one month after surgery using optical biometry and was compared between groups. Results: The mean difference in ACD (postoperative ACD minus preoperative ACD) was 0.68 ± 0.38 mm in the RRD group, 1.12 ± 0.32 mm in the MH group, 1.04 ± 0.56 mm in the ERM group, and 1.00 ± 0.47 mm in the cataract group. Postoperative ACD in the RRD group was shallower compared to the other groups. Conclusion: Postoperative ACD in patients with RRD is shallower compared to other groups, including patients with MH, making it one of the suspected causes of myopic shift in patients with RRD.","PeriodicalId":15372,"journal":{"name":"Journal of Clinical & Experimental Ophthalmology","volume":"44 1","pages":"1-6"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82685919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-01DOI: 10.35248/2155-9570.21.S13.002
Ye-hong He, Shasha Liu, F. Corvi, Tiffany L. M. Yeung, E. Tso, S. Sadda, K. K. Li
The current worldwide COVID-19 pandemic caused by SARS-CoV2 has generated an urgency to understand the implications of this disease in the eye. Possible retinal involvement by SARS-CoV2 infection has been a topic of heated debate. Objective: To determine whether retinal abnormalities can be identified on Optical Computed Tomography (OCT) in convalescent patients following COVID-19 infection. Methodology: This is a prospective, case controlled study that recruited COVID-19 patients who were admitted to the United Christian Hospital Hong Kong, China. At 2 months post-recovery, patients’ visual acuity, refraction were measured. Spectraldomain OCT of the macula to retinal nerve fiber layer and enhanced depth imaging were performed. Age-matched and refraction-matched healthy individuals that were not infected with COVID-19 were enrolled as controls. Qualitative and quantitative assessments of retinal abnormalities on OCT and retinal and choroidal layer thickness were done. Results: 20 subjects (40 eyes) with COVID-19 and 25 (50 eyes) healthy controls were enrolled. Structural OCT abnormalities were observed in 24% of control eyes and in 25% of COVID-19 subjects. No differences were observed between the post- COVID-19 cohort and the healthy controls for any qualitative retinal abnormalities or in any quantitative features including retinal volume, choroidal thickness, retinal layer thicknesses in various macular regions, and peripapillary nerve fiber layer thickness. Conclusion: Following full recovery from symptomatic COVID-19 infection, no significant abnormalities were evident on structural OCT as compared to controls. Although long-term damage to the retina appears to be uncommon after COVID-19 infection, this study provides valuable insight into the recovery process after COVID-19 and provides potential differentiating retinal features that should be considered in future studies involving a larger population.
{"title":"Retinal Findings on OCT in a COVID-19 Patient Cohort","authors":"Ye-hong He, Shasha Liu, F. Corvi, Tiffany L. M. Yeung, E. Tso, S. Sadda, K. K. Li","doi":"10.35248/2155-9570.21.S13.002","DOIUrl":"https://doi.org/10.35248/2155-9570.21.S13.002","url":null,"abstract":"The current worldwide COVID-19 pandemic caused by SARS-CoV2 has generated an urgency to understand the implications of this disease in the eye. Possible retinal involvement by SARS-CoV2 infection has been a topic of heated debate. Objective: To determine whether retinal abnormalities can be identified on Optical Computed Tomography (OCT) in convalescent patients following COVID-19 infection. Methodology: This is a prospective, case controlled study that recruited COVID-19 patients who were admitted to the United Christian Hospital Hong Kong, China. At 2 months post-recovery, patients’ visual acuity, refraction were measured. Spectraldomain OCT of the macula to retinal nerve fiber layer and enhanced depth imaging were performed. Age-matched and refraction-matched healthy individuals that were not infected with COVID-19 were enrolled as controls. Qualitative and quantitative assessments of retinal abnormalities on OCT and retinal and choroidal layer thickness were done. Results: 20 subjects (40 eyes) with COVID-19 and 25 (50 eyes) healthy controls were enrolled. Structural OCT abnormalities were observed in 24% of control eyes and in 25% of COVID-19 subjects. No differences were observed between the post- COVID-19 cohort and the healthy controls for any qualitative retinal abnormalities or in any quantitative features including retinal volume, choroidal thickness, retinal layer thicknesses in various macular regions, and peripapillary nerve fiber layer thickness. Conclusion: Following full recovery from symptomatic COVID-19 infection, no significant abnormalities were evident on structural OCT as compared to controls. Although long-term damage to the retina appears to be uncommon after COVID-19 infection, this study provides valuable insight into the recovery process after COVID-19 and provides potential differentiating retinal features that should be considered in future studies involving a larger population.","PeriodicalId":15372,"journal":{"name":"Journal of Clinical & Experimental Ophthalmology","volume":"34 1","pages":"1-8"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83615408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
1. Q: In the article, what explanations are suggested for the possible link between highly myopic eyes and increased rates of PCO? a. Delayed and incomplete capsular bend types of the Capsular bag and optic edge b. Toxic effect by the IOL contact on the posterior capsule c. “Barrier effect” by the IOL contact on the posterior capsule d. A and C A: d. a recent studies have highlighted the importance of the speed and type of capsular bend created by sharp DOI: 10.1111/ceo.13871
{"title":"Continuing Professional Development","authors":"","doi":"10.1111/ceo.13871","DOIUrl":"https://doi.org/10.1111/ceo.13871","url":null,"abstract":"1. Q: In the article, what explanations are suggested for the possible link between highly myopic eyes and increased rates of PCO? a. Delayed and incomplete capsular bend types of the Capsular bag and optic edge b. Toxic effect by the IOL contact on the posterior capsule c. “Barrier effect” by the IOL contact on the posterior capsule d. A and C A: d. a recent studies have highlighted the importance of the speed and type of capsular bend created by sharp DOI: 10.1111/ceo.13871","PeriodicalId":15372,"journal":{"name":"Journal of Clinical & Experimental Ophthalmology","volume":"38 1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76509426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-10-23DOI: 10.35248/2155-9570.20.11.860
Chiara Quisisana, L. Rossetti, A. Caretti, M. D. Cas, P. Fogagnolo
Aim: To evaluate the efficacy and safety of the new lipid tear substitute VisuEvo® in patients with dry eye disease (DED). Methods: 19 patients with evaporative or iatrogenic DED were enrolled and evaluated at baseline, week 2 and week 6. After baseline, they were instructed to self-administer VisuEvo three times daily for the whole study duration. Tear break-Up Time (TBUT), Schirmer I, Ferning, osmolarity, cytokine and lipid expression, ocular surface staining, patient satisfaction, and OSDI score were measured. Results: During the study, TBUT progressively increased from 3.0 ± 1.9 sec at baseline to 6.4 ± 1.7 sec at final visit (P<0.0001), and OSDI progressively decreased from 39 ± 12 at baseline to 20 ± 15 at final visit (P<0.0001). Osmolarity significantly reduced from 328 ± 14 mOsm/L at baseline to 306 ± 14 mOsm/L at final visit (P=0.03). A progressive reduction of cytokine and lipid expression was shown, being significant for IFN-? (P=0.01) and sphingosine (P=0.01). No changes were shown for Schirmer Test, conjunctival and corneal staining. Safety profile was excellent as no adverse events occurred; patients were highly satisfied by treatment. Conclusion: VisuEvo is an effective and safe option for DED management.
{"title":"The Efficacy of a New lubricating Eyedrop in a Lipid Vehicle for the Treatment of Dry Eye Disease","authors":"Chiara Quisisana, L. Rossetti, A. Caretti, M. D. Cas, P. Fogagnolo","doi":"10.35248/2155-9570.20.11.860","DOIUrl":"https://doi.org/10.35248/2155-9570.20.11.860","url":null,"abstract":"Aim: To evaluate the efficacy and safety of the new lipid tear substitute VisuEvo® in patients with dry eye disease (DED). \u0000 \u0000Methods: 19 patients with evaporative or iatrogenic DED were enrolled and evaluated at baseline, week 2 and week 6. After baseline, they were instructed to self-administer VisuEvo three times daily for the whole study duration. Tear break-Up Time (TBUT), Schirmer I, Ferning, osmolarity, cytokine and lipid expression, ocular surface staining, patient satisfaction, and OSDI score were measured. \u0000 \u0000Results: During the study, TBUT progressively increased from 3.0 ± 1.9 sec at baseline to 6.4 ± 1.7 sec at final visit (P<0.0001), and OSDI progressively decreased from 39 ± 12 at baseline to 20 ± 15 at final visit (P<0.0001). Osmolarity significantly reduced from 328 ± 14 mOsm/L at baseline to 306 ± 14 mOsm/L at final visit (P=0.03). A progressive reduction of cytokine and lipid expression was shown, being significant for IFN-? (P=0.01) and sphingosine (P=0.01). No changes were shown for Schirmer Test, conjunctival and corneal staining. Safety profile was excellent as no adverse events occurred; patients were highly satisfied by treatment. \u0000 \u0000Conclusion: VisuEvo is an effective and safe option for DED management.","PeriodicalId":15372,"journal":{"name":"Journal of Clinical & Experimental Ophthalmology","volume":"84 1","pages":"1-6"},"PeriodicalIF":0.0,"publicationDate":"2020-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85980683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-08-16DOI: 10.36648/2155-9570-C1-113
M. Haffar
Cataract surgery and dry eye syndrome. Visual outcomes. Patient's satisfaction. Matias S. Haffar Hospital Oftalmologico Santa Lucia, Argentina Abstract Visual Evoked Potential (VEP) measures the electrical activity in the entire vision system. When light enters the eye it is converted to electrical energy at the retina and travels through the optic nerve to the visual cortex which processes vision. The Diopsys VEP test measures the strength and speed of the retinal signal all the way to the visual cortex. VEP technology uniquely helps determine the communication between the eye and the brain. Electroretinography (ERG) measures retinal function. When light enters the eye it is converted into electrical energy by cones and rods, visual cells. ERG tests record the activity of the visual cells and thereby reflecting cell health and integrity. These two modalities are useful in diagnosing cellular pathology such as Age Related Maculopathy(AMD), glaucoma,Diabetic Macula Edema(DME) ,amblyopia,brain injury, stroke and other vision related issues. VEP is especially useful in Enfant and Pediatric exams to diagnose pathology. Biography: Matias S. Haffar, is an ophthalmologist who was born in Buenos Aires. Since the year 2006 he has been performing his activity uninterruptedly at the Hospital Santa Lucia in Buenos Aires, Argentina. He works as an instructor of surgeons in the Hospital Ocular Surgery Service, performing cataract, refractive, glaucoma, ocular surface and emergency surgeries.He also works as head of the anterior segment surgery service in the Centro de Investigacion y Tratamiento Ocular (CITO). He had worked as a teacher at the University of El Salvador in the advanced course of Ophthalmology, andnow he teaches in theadvanced course at the Universidad de Buenos Aires office (UBA) in Hospital Santa Lucia. . 29th International Conference on Insights in Ophthalmology; Webinars- June 17-18, 2020 Abstract Citation: Matias S. Haffar, Cataract surgery and dry eye syndrome. Visual outcomes. Patient's satisfaction., 29th International Conference on Insights in Ophthalmology; Webinars- June 17-18, 2020 (https://ophthalmology.insightconferences.com/ocm/2020/matias-haffar-hospital-santa-luc-a-buenos-aires-france )
白内障手术和干眼综合征。可视化的结果。病人的满意度。Matias s Haffar 医院Oftalmologico圣卢西亚,阿根廷抽象视觉诱发电位(VEP)测量电活动在整个视觉系统。当光线进入眼睛时，它在视网膜被转化为电能，并通过视神经到达处理视觉的视觉皮层。Diopsys VEP测试测量视网膜信号一直到视觉皮层的强度和速度。VEP技术独特地帮助确定眼睛和大脑之间的交流。视网膜电图(ERG)测量视网膜功能。当光线进入眼睛时，它被视锥细胞和视杆细胞转化为电能。ERG测试记录视觉细胞的活动，从而反映细胞的健康和完整性。这两种模式在诊断细胞病理，如年龄相关性黄斑病变(AMD)、青光眼、糖尿病性黄斑水肿(DME)、弱视、脑损伤、中风和其他视力相关问题时很有用。VEP在婴幼儿检查中诊断病理特别有用。简介:Matias S. Haffar是一名眼科医生，出生于布宜诺斯艾利斯。自2006年以来，他一直在阿根廷布宜诺斯艾利斯的圣卢西亚医院不间断地开展活动。他在医院眼科外科服务部门担任外科医生讲师，从事白内障、屈光、青光眼、眼表和急诊手术。他还担任眼科检查治疗中心(CITO)前节外科服务的负责人。他曾在萨尔瓦多大学担任高级眼科课程的教师，现在他在圣卢西亚医院的布宜诺斯艾利斯大学办公室(UBA)教授高级课程。第29届国际眼科会议;摘要来源:Matias S. Haffar，白内障手术和干眼综合征。可视化的结果。病人的满意度。，第29届国际眼科会议;网络研讨会- 2020年6月17日至18日(https://ophthalmology.insightconferences.com/ocm/2020/matias-haffar-hospital-santa-luc-a-buenos-aires-france)
{"title":"Cataract surgery and dry eye syndrome. Visual outcomes. Patient's satisfaction","authors":"M. Haffar","doi":"10.36648/2155-9570-C1-113","DOIUrl":"https://doi.org/10.36648/2155-9570-C1-113","url":null,"abstract":"Cataract surgery and dry eye syndrome. Visual outcomes. Patient's satisfaction. \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000Matias S. Haffar \u0000 \u0000 \u0000 \u0000Hospital Oftalmologico Santa Lucia, Argentina \u0000 \u0000 \u0000 \u0000Abstract \u0000 \u0000 \u0000 \u0000Visual Evoked Potential (VEP) measures the electrical activity in the entire vision system. When light enters the eye it is converted to electrical energy at the retina and travels through the optic nerve to the visual cortex which processes vision. The Diopsys VEP test measures the strength and speed of the retinal signal all the way to the visual cortex. VEP technology uniquely helps determine the communication between the eye and the brain. Electroretinography (ERG) measures retinal function. When light enters the eye it is converted into electrical energy by cones and rods, visual cells. ERG tests record the activity of the visual cells and thereby reflecting cell health and integrity. These two modalities are useful in diagnosing cellular pathology such as Age Related Maculopathy(AMD), glaucoma,Diabetic Macula Edema(DME) ,amblyopia,brain injury, stroke and other vision related issues. VEP is especially useful in Enfant and Pediatric exams to diagnose pathology. \u0000 \u0000Biography: \u0000 \u0000 \u0000 \u0000Matias S. Haffar, is an ophthalmologist who was born in Buenos Aires. Since the year 2006 he has been performing his activity uninterruptedly at the Hospital Santa Lucia in Buenos Aires, Argentina. He works as an instructor of surgeons in the Hospital Ocular Surgery Service, performing cataract, refractive, glaucoma, ocular surface and emergency surgeries.He also works as head of the anterior segment surgery service in the Centro de Investigacion y Tratamiento Ocular (CITO). He had worked as a teacher at the University of El Salvador in the advanced course of Ophthalmology, andnow he teaches in theadvanced course at the Universidad de Buenos Aires office (UBA) in Hospital Santa Lucia. \u0000 \u0000. \u0000 \u000029th International Conference on Insights in Ophthalmology; Webinars- June 17-18, 2020 \u0000 \u0000Abstract Citation: \u0000 \u0000 \u0000Matias S. Haffar, Cataract surgery and dry eye syndrome. Visual outcomes. Patient's satisfaction., 29th International Conference on Insights in Ophthalmology; Webinars- June 17-18, 2020 (https://ophthalmology.insightconferences.com/ocm/2020/matias-haffar-hospital-santa-luc-a-buenos-aires-france )","PeriodicalId":15372,"journal":{"name":"Journal of Clinical & Experimental Ophthalmology","volume":"256 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79520273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-08-16DOI: 10.36648/2155-9570-C1-115
Romana Fazal
Periocular steroids for macular edema associated with retinal arterio-venous malformation Romana Fazal Aravind Eye Hospital and Post graduate Institute of Ophthalmology, India Abstract Retinal racemose hemangiomas are vascular malformations comprising of direct arteriovenous communications in the retina which may sometimes present with defective vision. Exudation and neurosensory detachment are some of the complications which may be responsible for decreased visual acuity. We describe a case of a 38-year-old male presenting with unilateral group II retinal racemose hemangioma complicated with macular edema. Intravitreal bevacizumab was injected after which an increase in edema was noted at one month follow up. He was subsequently treated with posterior sub tenon injection of triamcinolone following which there was a prompt decrease in the intra retinal and subretinal fluid with simultaneous improvement in vision. The visual acuity was maintained and no recurrence was seen till six months after successful treatment. Biography: Romana Fazal has completed her MBBS from West Bengal university at the age of 24 years and DNB from Aravind Eye Hospital, Pondicherry. She is currently pursuing her fellowship in Vitreo retinal diseases at Aravind Eye Hospital, Pondicherry. She has 3 publications in reputed national and international journals and number of presentations in national level conferences. 29th International Conference on Insights in Ophthalmology; Webinars- June 17-18, 2020 Abstract Citation: Romana Fazal, Periocular steroids for macular edema associated with retinal arterio-venous malformation, 29th International Conference on Insights in Ophthalmology; Webinars- June 17-18, 2020 (https://ophthalmology.insightconferences.com/abstract/2020/periocular-steroids-for-macular-edema-associated-with-retinal-arterio-venous-malformation )
{"title":"Periocular steroids for macular edema associated with retinal arterio-venous malformation","authors":"Romana Fazal","doi":"10.36648/2155-9570-C1-115","DOIUrl":"https://doi.org/10.36648/2155-9570-C1-115","url":null,"abstract":"Periocular steroids for macular edema associated with retinal arterio-venous malformation \u0000 \u0000 \u0000 \u0000Romana Fazal \u0000 \u0000Aravind Eye Hospital and Post graduate Institute of Ophthalmology, India \u0000 \u0000 \u0000 \u0000Abstract \u0000 \u0000Retinal racemose hemangiomas are vascular malformations comprising of direct arteriovenous communications in the retina which may sometimes present with defective vision. Exudation and neurosensory detachment are some of the complications which may be responsible for decreased visual acuity. We describe a case of a 38-year-old male presenting with unilateral group II retinal racemose hemangioma complicated with macular edema. Intravitreal bevacizumab was injected after which an increase in edema was noted at one month follow up. He was subsequently treated with posterior sub tenon injection of triamcinolone following which there was a prompt decrease in the intra retinal and subretinal fluid with simultaneous improvement in vision. The visual acuity was maintained and no recurrence was seen till six months after successful treatment. \u0000 \u0000Biography: \u0000 \u0000 \u0000 \u0000Romana Fazal has completed her MBBS from West Bengal university at the age of 24 years and DNB from Aravind Eye Hospital, Pondicherry. She is currently pursuing her fellowship in Vitreo retinal diseases at Aravind Eye Hospital, Pondicherry. She has 3 publications in reputed national and international journals and number of presentations in national level conferences. \u0000 \u0000 \u0000 \u000029th International Conference on Insights in Ophthalmology; Webinars- June 17-18, 2020 \u0000 \u0000 \u0000 \u0000Abstract Citation: \u0000 \u0000 \u0000Romana Fazal, Periocular steroids for macular edema associated with retinal arterio-venous malformation, 29th International Conference on Insights in Ophthalmology; Webinars- June 17-18, 2020 (https://ophthalmology.insightconferences.com/abstract/2020/periocular-steroids-for-macular-edema-associated-with-retinal-arterio-venous-malformation )","PeriodicalId":15372,"journal":{"name":"Journal of Clinical & Experimental Ophthalmology","volume":"618 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77500927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：